TY - JOUR
T1 - HPLC-atmospheric pressure chemical ionization mass spectrometric method for enantioselective determination of R,S-propranolol and R,S-hyoscyamine in human plasma
AU - Siluk, Danuta
AU - Mager, Donald E.
AU - Gronich, Naomi
AU - Abernethy, Darrell
AU - Wainer, Irving W.
N1 - Funding Information:
This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.
PY - 2007/11/15
Y1 - 2007/11/15
N2 - A method for the simultaneous determination of R- and S-propranolol and R- and S-hyoscyamine in human plasma was developed, validated and applied to the analysis of samples from a clinical study. Sample preparation was performed by solid-phase extraction of 2 ml of human plasma using Oasis MCX cartridges and the enantioselective separations were achieved using a Chirobiotic V chiral stationary phase. The chromatography was carried out using gradient elution with a mobile phase composed of methanol:acetic acid:triethylamine which was varied from 100:0.05:0.04 to 100:0.05:0.1 (v/v/v) over 30 min and delivered at a flow rate 1 ml/min. The internal standard was R,S-propranolol-d7 and the analytes were quantified using a single quadrupole mass spectrometer employing APCI interface operated in the positive ion mode with single ion monitoring. The enantioselective separation factors, α, were 1.15 and 1.07 for S- and R-propranolol and R- and S-hyoscyamine, respectively. The standard curves were linear for all target compounds with coefficients of determination (r2) ranging from 0.9977 to 0.9999. The intra- and inter-day precision and accuracy were ≤13.2% and ≤10.2%, respectively. The assay was used to analyze plasma samples from seven subjects who had received i.v. infusions of R,S-propranolol and R,S-hyoscyamine. The initial data indicate that R-propranolol was eliminated faster than S-propranolol (CL/f = 2.34 ± 0.13 L/kg min vs. 2.07 ± 0.22 L/kg min) and that R-propranolol had a larger volume of distribution at steady-state (Vss/f = 705 ± 165 L/kg vs. 589 ± 130 L/kg). In the case of R,S-hyoscyamine, S-hyoscyamine was eliminated faster than R-hyoscyamine (CL/f = 0.0537 ± 0.0073 L/kg min vs. 0.0439 ± 0.0086 L/kg min), while the volumes of distribution at steady-state were similar for the hyoscyamine enantiomers (Vss/f = 7.82 ± 2.66 L/kg vs. 7.73 ± 1.39 L/kg).
AB - A method for the simultaneous determination of R- and S-propranolol and R- and S-hyoscyamine in human plasma was developed, validated and applied to the analysis of samples from a clinical study. Sample preparation was performed by solid-phase extraction of 2 ml of human plasma using Oasis MCX cartridges and the enantioselective separations were achieved using a Chirobiotic V chiral stationary phase. The chromatography was carried out using gradient elution with a mobile phase composed of methanol:acetic acid:triethylamine which was varied from 100:0.05:0.04 to 100:0.05:0.1 (v/v/v) over 30 min and delivered at a flow rate 1 ml/min. The internal standard was R,S-propranolol-d7 and the analytes were quantified using a single quadrupole mass spectrometer employing APCI interface operated in the positive ion mode with single ion monitoring. The enantioselective separation factors, α, were 1.15 and 1.07 for S- and R-propranolol and R- and S-hyoscyamine, respectively. The standard curves were linear for all target compounds with coefficients of determination (r2) ranging from 0.9977 to 0.9999. The intra- and inter-day precision and accuracy were ≤13.2% and ≤10.2%, respectively. The assay was used to analyze plasma samples from seven subjects who had received i.v. infusions of R,S-propranolol and R,S-hyoscyamine. The initial data indicate that R-propranolol was eliminated faster than S-propranolol (CL/f = 2.34 ± 0.13 L/kg min vs. 2.07 ± 0.22 L/kg min) and that R-propranolol had a larger volume of distribution at steady-state (Vss/f = 705 ± 165 L/kg vs. 589 ± 130 L/kg). In the case of R,S-hyoscyamine, S-hyoscyamine was eliminated faster than R-hyoscyamine (CL/f = 0.0537 ± 0.0073 L/kg min vs. 0.0439 ± 0.0086 L/kg min), while the volumes of distribution at steady-state were similar for the hyoscyamine enantiomers (Vss/f = 7.82 ± 2.66 L/kg vs. 7.73 ± 1.39 L/kg).
KW - Atropine
KW - Chirobiotic V chiral stationary phase
KW - LC-APCI-MS
KW - Propranolol
UR - http://www.scopus.com/inward/record.url?scp=35748956837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35748956837&partnerID=8YFLogxK
U2 - 10.1016/j.jchromb.2007.09.035
DO - 10.1016/j.jchromb.2007.09.035
M3 - Article
C2 - 17951120
AN - SCOPUS:35748956837
SN - 1570-0232
VL - 859
SP - 213
EP - 221
JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
IS - 2
ER -